Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Tech Assessment: Rules For Referral Will Be Determined, Published

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific VP-Federal Affairs, Reimbursement & Outcomes Planning Randel Richner will advise CMS on draft guidelines for referring national coverage determinations to external technology assessments or the Medicare Coverage Advisory Committee

You may also be interested in...



Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period

Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee

Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period

Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee

CMS’ First Coverage Timeliness Report To Congress: NCDs Averaged 156 Days

Average timeframes for each step of CMS' national coverage processes in 2001 were significantly shorter than prospective targets established by the agency, according to a 11June HHS report to Congress

UsernamePublicRestriction

Register

LL1135009

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel